1. Department of Nuclear Medicine, Cochin Hospital, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris Descartes University, Paris, France;
2. Santa Maria Nuova Hospital–IRCCS Reggio Emilia, Reggio Emilia, Italy;
3. Department of Clinical Physiology, Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark;
4. Hematology Department, INSERM 1231, University Hospital, Dijon, France;
5. Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy;
6. Lymphoma Academic Research Organization (LYSARC) Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil, France;
7. Department of Nuclear Medicine, Centre de Lutte Contre le Cancer François Baclesse, Caen, France;
8. Nuclear Medicine Unit, Ospedale Santo Stefano, Prato, Italy;
9. Hematology, Hopital Saint-Louis, AP-HP, Paris, France;
10. Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;
11. Hematology, Hôpital Cochin, Paris, France;
12. European Organisation for Research and Treatment of Cancer, Brussels, Belgium;
13. Biostatistical Department, LYSARC, Centre Hospitalier Lyon Sud, Lyon, France;
14. Nuclear Medicine Division, Centre Hospitalo-Universitaire Université Catholique de Louvain, Namur, Yvoir, Belgium;
15. Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark;
16. Department of Oncology, University of Turin, Turin, Italy;
17. Hematology Department, Centre Hospitalo-Universitaire Université Catholique de Louvain, Namur, Yvoir, Belgium;
18. Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil, France; and
19. Université Paris Est, Créteil, France